{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:59:40Z","timestamp":1785002380352,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["207285"],"award-info":[{"award-number":["207285"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI069924"],"award-info":[{"award-number":["U01AI069924"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vhri.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T23:41:29Z","timestamp":1662075689000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review"],"prefix":"10.1016","volume":"32","author":[{"given":"Rowan","family":"Iskandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoun","family":"Taghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichor M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Rohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vhri.2022.07.001_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020;70(4):313]","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vhri.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.puhe.2021.04.014","article-title":"Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"195","author":"Yimer","year":"2021","journal-title":"Public Health"},{"issue":"6","key":"10.1016\/j.vhri.2022.07.001_bib3","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vhri.2022.07.001_bib4","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","year":"2020"},{"issue":"6","key":"10.1016\/j.vhri.2022.07.001_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.vhri.2022.07.001_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0956462413491735","article-title":"Incidence and progression of cervical lesions in women with HIV: a systematic global review","volume":"25","author":"Denslow","year":"2014","journal-title":"Int J STD AIDS"},{"issue":"9","key":"10.1016\/j.vhri.2022.07.001_bib8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/cid\/ciy1123","article-title":"Residual or recurrent precancerous lesions after treatment of cervical lesions in human immunodeficiency virus-infected women: a systematic review and meta-analysis of treatment failure","volume":"69","author":"Debeaudrap","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vhri.2022.07.001_bib9","series-title":"WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention","year":"2021"},{"issue":"10224","key":"10.1016\/j.vhri.2022.07.001_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vhri.2022.07.001_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-015-1332-8","article-title":"Systematic review of model-based cervical screening evaluations","volume":"15","author":"Mendes","year":"2015","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.vhri.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"issue":"4","key":"10.1016\/j.vhri.2022.07.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018527","article-title":"Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation","volume":"6","author":"Atashili","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/QAI.0000000000001778","article-title":"Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: a mathematical modeling study","volume":"79","author":"Campos","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.vhri.2022.07.001_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000002552","article-title":"Modeling the impact of voluntary medical male circumcision on cervical cancer in Uganda","volume":"86","author":"Davis","year":"2021","journal-title":"J\u00a0Acquir Immune Defc Syndr"},{"issue":"3","key":"10.1016\/j.vhri.2022.07.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248832","article-title":"Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: the HPV in Africa Research Partnership (HARP) study","volume":"16","author":"Devine","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vhri.2022.07.001_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221495","article-title":"Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa","volume":"14","author":"Dreyer","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-130-2-199901190-00003","article-title":"The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women","volume":"130","author":"Goldie","year":"1999","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.vhri.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.285.24.3107","article-title":"Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness","volume":"285","author":"Goldie","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9343(01)00780-X","article-title":"Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus","volume":"111","author":"Goldie","year":"2001","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.vhri.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.vhri.2022.07.001_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231388","article-title":"The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: a modelling study","volume":"15","author":"Hall","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.33533","article-title":"Elimination of cervical cancer in Tanzania: modelled analysis of elimination in the context of endemic HIV infection and active HIV control","volume":"149","author":"Hall","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vhri.2022.07.001_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12879-015-1295-z","article-title":"Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence","volume":"15","author":"Li","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vhri.2022.07.001_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141969","article-title":"Costs and cost effectiveness of three approaches for cervical cancer screening among HIV-positive women in Johannesburg, South Africa","volume":"10","author":"Lince-Deroche","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vhri.2022.07.001_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101306","article-title":"Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: a mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence","volume":"45","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.vhri.2022.07.001_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001886","article-title":"The impact of scaling up cervical cancer screening and treatment services among women living with HIV in Kenya: a modelling study","volume":"5","author":"Perez-Guzman","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vhri.2022.07.001_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12913-015-1163-y","article-title":"Cost-effectiveness of using the cervex-brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis","volume":"15","author":"Schnippel","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"44","key":"10.1016\/j.vhri.2022.07.001_bib30","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1016\/j.vaccine.2009.08.004","article-title":"The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa","volume":"27","author":"Sinanovic","year":"2009","journal-title":"Vaccine"},{"issue":"32 Pt A","key":"10.1016\/j.vhri.2022.07.001_bib31","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1016\/j.vaccine.2018.02.023","article-title":"Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa","volume":"36","author":"Tan","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib32","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1002\/ijc.26472","article-title":"Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country","volume":"131","author":"Vanni","year":"2012","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.vhri.2022.07.001_bib33","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.33716","article-title":"Modelling the impact of prevention strategies on cervical cancer incidence in South Africa","volume":"149","author":"van Schalkwyk","year":"2021","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2008.08.030","article-title":"Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa","volume":"112","author":"Vijayaraghavan","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vhri.2022.07.001_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12962-017-0075-6","article-title":"Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya","volume":"15","author":"Zimmermann","year":"2017","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vhri.2022.07.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2019.100184","article-title":"HPV-FRAME: a consensus statement and quality framework for modelled evaluations of HPV-related cancer control","volume":"8","author":"Canfell","year":"2019","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vhri.2022.07.001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106438","article-title":"A\u00a0proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer","volume":"144","author":"Campos","year":"2021","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.vhri.2022.07.001_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on good research practices--modeling studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.vhri.2022.07.001_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205543","article-title":"A\u00a0theoretical foundation for state-transition cohort models in health decision analysis","volume":"13","author":"Iskandar","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2022.07.001_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jval.2020.01.001","article-title":"Value of information analysis for research decisions-an introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Fenwick","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2022.07.001_bib41","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.clinthera.2010.06.017","article-title":"Proceedings of the modeling evidence in HPV pre-conference workshop in Malm\u00f6, Sweden, May 9-10, 2009","volume":"32","author":"Craig","year":"2010","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.vhri.2022.07.001_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vhri.2022.07.001_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","article-title":"Economic foundations of cost-effectiveness analysis","volume":"16","author":"Garber","year":"1997","journal-title":"J\u00a0Health Econ"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:12:59Z","timestamp":1761941579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109922001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"alternative-id":["S2212109922001327"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2022.07.001","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}